Skip to Content
Get key facts and figures about chronic dry eye

Tobramycin ophthalmic Pregnancy and Breastfeeding Warnings

Tobramycin ophthalmic is also known as: AK-Tob, Tobralcon, Tobrasol, Tobrex, Tomycine

Medically reviewed on January 3, 2018

Tobramycin ophthalmic Pregnancy Warnings

Tobramycin ophthalmic has been assigned to pregnancy category B by the FDA. Animal reproductive studies revealed no evidence of impaired fertility or harm to the fetus at doses up to 33 times the human systemic dose. There are no controlled data in human pregnancy. Tobramycin ophthalmic should only be given during pregnancy when clearly needed.

See references

Tobramycin ophthalmic Breastfeeding Warnings

There are no data on the excretion of tobramycin ophthalmic into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue the drug or to discontinue nursing, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Tobrex (tobramycin ophthalmic)." Alcon Laboratories Inc, Fort Worth, TX.

References for breastfeeding information

  1. "Product Information. Tobrex (tobramycin ophthalmic)." Alcon Laboratories Inc, Fort Worth, TX.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide